Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
ATTAIN-2 enrolled over 1,600 adults with type 2 diabetes and showed meaningful weight reductions of 5.1 to 9.6 percent depending on dose, along with significant improvements in blood sugar control and cardiometabolic markers including waist circumference, blood pressure, and cholesterol
doi: 10.3390/jof7030232 341 RobbinsN.CowenL
Long-Term Health Considerations For some individuals, especially those with obesity-related health conditions (like type 2 diabetes, high blood pressure, or cardiovascular issues), staying on GLP-1 medications for the long term might be necessary to manage overall health, not just weight loss
The 1200mg dose provides therapeutic levels that cannot be achieved through oral supplementation due to poor absorption
US$ 23.05
US$ 23.69
US$ 24.50
US$ 22.78
US$ 28.73
US$ 23.84
